Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration (AMD)
This study is currently recruiting participants.
Verified September 2012 by Lions Eye Institute, Perth, Western Australia
Lions Eye Institute, Perth, Western Australia
Avalanche Biotechnologies, Inc.
Information provided by (Responsible Party):
Prof. P. Elizabeth Rakoczy, Lions Eye Institute, Perth, Western Australia
First received: December 14, 2011
Last updated: September 11, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2014|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|